By Dr Angeline Lee
Health Correspondent, Wire World News
February 24, 2026
From Hollywood red carpets to Dubai brunch tables and clinics in São Paulo, one small injection has become the world’s most controversial health accessory. Weight‑loss drugs originally developed for diabetes – like Ozempic, Wegovy and their copycats – have gone viral, literally reshaping bodies and health debates from Los Angeles to Lagos. But behind the dramatic “before and after” photos lies a bigger question: are we fixing a global health crisis or creating a new kind of dependency?
The numbers are stark. Obesity rates have soared on every continent. In Mexico and the United States, more than a third of adults live with obesity. In Gulf countries, rapid urbanisation and extreme heat have made outdoor activity rare, driving up diabetes and heart disease. Even in regions once associated with undernutrition – like parts of South Asia and Africa – cheap ultra‑processed foods and sugary drinks are fuelling a double burden: kids who are both overweight and lacking essential nutrients.
Enter the injectable revolution. These drugs mimic gut hormones that regulate appetite, helping people feel full sooner and eat less. For someone with severe obesity and diabetes, they can be life‑changing: better blood sugar control, weight loss, fewer complications. In clinical trials, patients lost 10–20% of their body weight, and some reversed conditions that once seemed permanent. For public health experts, this is no small thing.
But the global rollout has been messy and deeply unequal. In wealthy countries, influencers show off shrinking waistlines on TikTok, while hospitals struggle to keep enough supply for patients who actually need the drugs for diabetes. In middle‑income nations like Brazil, Turkey or South Africa, private clinics market them aggressively to celebrities and the upper middle class, even as public health systems strain to afford a fraction of the cost. Meanwhile, for millions in low‑income countries, these drugs remain completely out of reach.
Side effects – nausea, digestive issues, potential long‑term risks – are real. So is the psychological impact. Many users quickly discover that stopping the injections often brings weight back, sometimes rapidly. That means the “miracle” can turn into a long‑term relationship with a very expensive medication. Critics argue that we are medicalising what is largely a social and environmental problem: cities designed for cars, not walking; food systems flooded with cheap, unhealthy calories; work lives that leave little time for cooking or exercise.
There’s also a cultural backlash brewing. In France, Italy and Japan, where food is deeply tied to identity and pleasure, people worry about a future where shared meals are replaced by appetite suppression. In South Korea and parts of Latin America, where beauty standards are already punishing, young people feel fresh pressure to inject their way to an “ideal” body. Social media algorithms amplify this, pushing weight‑loss content to teens who are still developing physically and emotionally.
Yet the other extreme – shaming or dismissing people who choose these drugs – is equally harmful. For many, especially those who’ve battled weight and stigma for years, these medications offer a tool they’ve never had before. In countries like the UK, Canada and Australia, patient groups argue that access should be expanded, not restricted, as part of a broader strategy that includes nutrition, mental health support and physical activity.
The most honest answer may be that these drugs are neither heroes nor villains. They are powerful tools dropped into a world that still hasn’t addressed why so many people struggle with weight in the first place. Without changes to food policy, urban design and work culture, injections risk becoming another expensive bandage on a wound that keeps reopening.
The global health story to watch now isn’t just how many kilos people lose, but who gets access, who profits, and whether we use this moment to rethink what “healthy” truly means. Is it a number on a scale – or a world where our environments stop pushing us toward illness in the first place?
